This application is a competitive renewal of the UCLA Center for Advancing Longitudinal Drug Abuse Research (CALDAR;P30DA016383) funded by NIDA since September 2005. The overarching mission of CALDAR is to promote and support rigorous longitudinal research to enhance scientific understanding of how drug use patterns evolve and interplay with HIV, drug treatment services, and other service systems (e.g., criminal justice, mental health) over time. Building upon the life course drug use framework and considerable empirical examinations of drug use trajectories and related HIV risk, mental health, and criminal involvement, during this renewal period the Center's theme will focus on recovery from drug dependence. To support the Center's mission, thematic focus on recovery, and research projects, CALDAR comprises three Cores: (1) the Coordination &Integration Core will provide overall Center leadership, administrative support, coordination across Cores, and support for the pilot project program;(2) the Research &Methods Support Core will identify priorities for longitudinal research on drug abuse and recovery and will enhance the quality of attendant methodological procedures and approaches;and (3) the Statistical Support &Analysis Core will support longitudinal statistical applications and analyses. All Cores will be involved in CALDAR's education, mentoring, and training activities. The chronic nature of drug dependence necessitates a longitudinal approach to better understand and address addiction and to promote recovery. Given the complexity of conducting quality longitudinal studies, the rapid development of longitudinal statistical modeling techniques, and the challenges in analyzing longitudinal data, the Center's infrastructure greatly enhances the efficiency and quality of Center-affiliated projects, resulting in enhanced capacity to conduct and integrate longitudinal research projects and address recovery-related issues. CALDAR serves a crucial role as a national resource for advancing longitudinal research on drug abuse and recovery via its scientific findings and dissemination, data sharing, education and training, and support of emerging investigators.

Public Health Relevance

The overarching mission of CALDAR is to promote and support rigorous longitudinal research to enhance scientific understanding of how drug use patterns evolve and interplay with HIV, drug treatment services, and other service systems (e.g., criminal justice, mental health) over time. Findings of the Center have clinical and policy implications for developing and applying strategies to address drug addiction and to promote recovery, as well as related issues in HIV, mental health, and criminality.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA016383-08
Application #
8309316
Study Section
Special Emphasis Panel (ZDA1-EXL-T (06))
Program Officer
Wiley, Tisha R A
Project Start
2003-04-01
Project End
2015-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
8
Fiscal Year
2012
Total Cost
$855,466
Indirect Cost
$197,833
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
He, Qinghua; Huang, Xiaolu; Turel, Ofir et al. (2018) Presumed structural and functional neural recovery after long-term abstinence from cocaine in male military veterans. Prog Neuropsychopharmacol Biol Psychiatry 84:18-29
Hser, Yih-Ing; Huang, David; Saxon, Andrew J et al. (2017) Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine?+?Naloxone and Methadone. J Addict Med 11:63-69
Hser, Yih-Ing; Mooney, Larissa J; Saxon, Andrew J et al. (2017) High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System. J Addict Med 11:315-319
Chang, Kun-Chia; Wang, Jung-Der; Saxon, Andrew et al. (2017) Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan. Int J Drug Policy 43:1-6
Hser, Yih-Ing; Mooney, Larissa J; Huang, David et al. (2017) Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. J Subst Abuse Treat 81:53-58
Wang, Linwei; Min, Jeong Eun; Krebs, Emanuel et al. (2017) Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users. Int J Drug Policy 49:32-40
Krebs, Emanuel; Min, Jeong E; Evans, Elizabeth et al. (2017) Estimating State Transitions for Opioid Use Disorders. Med Decis Making 37:483-497
Hser, Yih-Ing; Mooney, Larissa J; Saxon, Andrew J et al. (2017) Chronic pain among patients with opioid use disorder: Results from electronic health records data. J Subst Abuse Treat 77:26-30
Krebs, Emanuel; Urada, Darren; Evans, Elizabeth et al. (2017) The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addiction 112:838-851
Hser, Yih-Ing; Evans, Elizabeth; Huang, David et al. (2016) Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addiction 111:695-705

Showing the most recent 10 out of 155 publications